Group 1: Surgical Robotics - A record-breaking remote robotic surgery was successfully performed over a distance of 12,035 kilometers, certified by Guinness World Records as the "farthest distance for remote robotic surgery" [2] - The surgery was conducted by Dr. Leandro Totti in Kuwait using the Chinese-developed Jingfeng® surgical robot, demonstrating a bidirectional communication delay of only 199 milliseconds, ensuring precision and safety during the procedure [4] Group 2: Pharmaceutical Innovations - The first AI-enabled formulation drug in China, MTS-004, has successfully reached the primary endpoint of Phase III clinical trials, marking a significant milestone in the pharmaceutical industry [6] - MTS-004 is designed for the treatment of Pseudobulbar Affect (PBA) and features an orally disintegrating tablet formulation that improves patient compliance by dissolving quickly in the mouth without water [8] Group 3: Medical Devices - The GuiTracker® hard guidewire developed by Shanghai Shape Memory Alloy Materials Co., Ltd. has received approval for market launch, aimed at enhancing the performance of cardiovascular and peripheral vascular interventional surgeries [10] - The guidewire addresses clinical challenges by providing high support and stability, crucial for navigating complex vascular conditions during procedures [10] Group 4: Advanced Therapies - C-CAR168, a novel CAR-T therapy developed by Xibiman Biotechnology, has been selected as a breakthrough abstract for the 2025 American College of Rheumatology (ACR) Convergence, highlighting its potential in treating refractory autoimmune diseases [12][13] Group 5: Brain Research Initiatives - The China Brain Multi-omics Atlas Project (CBMAP) has officially launched, aiming to create a comprehensive molecular map of the human brain, focusing on the East Asian population [15] - M20 Genomics' VITA high-throughput single-cell full-length transcriptome platform has been chosen as a core method for this project, enabling high-quality analysis of precious brain tissue samples [19] Group 6: Medical Materials - The animal study results of UniPearls®, a new generation drug-loaded embolic microsphere, have been published in a leading biomaterials journal, demonstrating its effectiveness and safety for use in transarterial embolization [21][24] Group 7: Investment Landscape - Sequoia China has invested in over 200 innovative healthcare companies, covering various sectors including innovative drugs, medical devices, and digital healthcare, with more than 45 companies having completed IPOs [25]